Edition:
India

Cellmid Ltd (CDY.AX)

CDY.AX on Australia Stock Exchange

0.24AUD
21 Nov 2019
Change (% chg)

-- (--)
Prev Close
$0.24
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
70,881
52-wk High
$0.32
52-wk Low
$0.17

Latest Key Developments (Source: Significant Developments)

Cellmid Signs Trading Agreement With API/Priceline
Wednesday, 6 Nov 2019 

Nov 6 (Reuters) - Cellmid Ltd ::SIGNS TRADING AGREEMENT WITH API/PRICELINE.CONFIRMS GUIDANCE THAT IT IS ON TRACK TO REACH OPERATIONAL PROFITABILITY IN CONSUMER HEALTH BUSINESS IN FY2020.UNIT ENTERED INTO NATIONAL TRADING AGREEMENT WITH API FOR RANGING OF ITS ÉVOLIS PROFESSIONAL ANTI- AGING HAIR CARE PRODUCTS.  Full Article

Cellmid Posts Q1 Sales Of $1.38 Million
Wednesday, 23 Oct 2019 

Oct 23 (Reuters) - Cellmid Ltd ::GENERATED $1.38 MILLION IN SALES IN Q1 FY2020, ON PAR WITH PCP.  Full Article

Cellmid Signs New Distribution Agreement For Évolis And Opens In Europe
Tuesday, 1 Oct 2019 

Oct 1 (Reuters) - Cellmid Ltd ::CELLMID - CELLMID HAS ENTERED INTO A SUPPLY AGREEMENT FOR ITS ÉVOLIS PROFESSIONAL ANTI-AGING HAIR CARE AND HAIR LOSS PRODUCTS WITH DOUGLAS GMBH.CELLMID -SIGNED EXCLUSIVE DISTRIBUTION AGREEMENT WITH AEON INTERNATIONAL FOR ÉVOLIS PROFESSIONAL TO BE SOLD IN CHINESE CROSS-BORDER E-COMMERCE MARKET.  Full Article

Cellmid Receives Notification Of Intention To Grant "Improved Midkine Antibody" Patent
Thursday, 22 Aug 2019 

Aug 22 (Reuters) - Cellmid Ltd ::CELLMID - GOT NOTIFICATION OF INTENTION TO GRANT FROM EUROPEAN PATENT OFFICE FOR "IMPROVED MIDKINE ANTIBODY" PATENT IN KEY EUROPEAN TERRITORIES.  Full Article

Cellmid Generated $2.45 Million In Sales In Q4 FY2019, Up 83%
Friday, 26 Jul 2019 

July 26 (Reuters) - Cellmid Ltd ::GENERATED $2.45 MILLION IN SALES IN Q4 FY2019, UP 83%.  Full Article

Cellmid Sees Q4 Sales At $2.45 Million
Thursday, 4 Jul 2019 

July 4 (Reuters) - Cellmid Ltd ::SALES FOR 4Q FY2019 ARE EXPECTED TO REACH $2.45 MILLION.  Full Article

Cellmid On Track To Achieve Record Revenue In Fy2019
Tuesday, 28 May 2019 

May 28 (Reuters) - Cellmid Ltd ::Q3 SALES UP 25% ON PREVIOUS CORRESPONDING QUARTER.ON TRACK TO ACHIEVE RECORD REVENUE IN FY2019.  Full Article

Cellmid Posts H1 Revenue Of $3.6 Mln
Thursday, 21 Feb 2019 

Feb 21 (Reuters) - Cellmid Ltd ::H1 REVENUE OF $3.6 MILLION WAS UP 12%.HY NET LOSS AFTER TAX FOR THE PERIOD ATTRIBUTABLE TO MEMBERS $3.5 MILLION VERSUS $1.1 MILLION.  Full Article

Cellmid Announces New Patents for Midkine Antibodies in USA and Europe
Wednesday, 7 Nov 2018 

Nov 7 (Reuters) - Cellmid Ltd ::EUROPEAN PATENT OFFICE ISSUES INTENTION TO GRANT FOR MIDKINE N-DOMAIN ANTIBODY PATENT.PATENT COVERING LYRAMID'S ANTIBODY RECOGNIZING N-DOMAIN OF MIDKINE GRANTED IN USA.HAS RECENTLY FILED TWO NEW PROVISIONAL PATENT APPLICATIONS FOR LYRAMID'S N-DOMAIN ANTIBODIES.  Full Article

Cellmid Enter Agreement With Labo International S.R.L
Wednesday, 4 Apr 2018 

April 4 (Reuters) - Cellmid Ltd ::ENTERED INTO AN AGREEMENT WITH LABO INTERNATIONAL S.R.L TO UNDERTAKE EXCLUSIVE DISTRIBUTION OF FILLERINA.  Full Article